From: Development and validation of a Bayesian survival model for inclusion body myositis
Validation study
N
Study Duration (median)
Observed deaths
Predicted deaths
(base-case model)
Predicted deaths (saturated model)
Cox et al. [5] (overall)
64
12
72% [61%; 83%]
61% [57%; 66%]
76% [64%; 85%]
Benveniste et al. [4]
136
2.5
18% [12%; 25%]
14% [11%; 17%]
35% [27%; 43%]